Cargando…
Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China
BACKGROUND: Few studies have investigated the association between body mass index (BMI) and breast cancer with consideration to estrogen/progesterone/human epidermal growth factor type 2 receptor status (ER/PR/HER2) in the breast tissue among Chinese pre- and post-menopausal women. METHODS: Four tho...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906138/ https://www.ncbi.nlm.nih.gov/pubmed/24489874 http://dx.doi.org/10.1371/journal.pone.0087224 |
_version_ | 1782301446297878528 |
---|---|
author | Li, Jing Huang, Yuan Zhang, Bao-Ning Fan, Jin-Hu Huang, Rong Zhang, Pin Wang, Shu-Lian Zheng, Shan Zhang, Bin Yang, Hong-Jian Xie, Xiao-Ming Tang, Zhong-Hua Li, Hui He, Jian-Jun Hsieh, Evelyn Qiao, You-Lin Li, Jia-Yuan |
author_facet | Li, Jing Huang, Yuan Zhang, Bao-Ning Fan, Jin-Hu Huang, Rong Zhang, Pin Wang, Shu-Lian Zheng, Shan Zhang, Bin Yang, Hong-Jian Xie, Xiao-Ming Tang, Zhong-Hua Li, Hui He, Jian-Jun Hsieh, Evelyn Qiao, You-Lin Li, Jia-Yuan |
author_sort | Li, Jing |
collection | PubMed |
description | BACKGROUND: Few studies have investigated the association between body mass index (BMI) and breast cancer with consideration to estrogen/progesterone/human epidermal growth factor type 2 receptor status (ER/PR/HER2) in the breast tissue among Chinese pre- and post-menopausal women. METHODS: Four thousand two hundred and eleven breast cancer patients were selected randomly from seven geographic regions of China from 1999 to 2008. Demographic data, risk factors, pathologic features, and biological receptor status of cases were collected from the medical charts. Chi-square test, fisher exact test, rank-correlation analysis, and multivariate logistic regression model were adopted to explore whether BMI differed according to biological receptor status in pre- and post-menopausal women. RESULTS: Three thousand two hundred and eighty one eligible cases with BMI data were included. No statistically significant differences in demographic characteristics were found between the cases with BMI data and those without. In the rank-correlation analysis, the rates of PR+ and HER2+ were positively correlated with increasing BMI among post-menopausal women (r(s BMI, PR+) = 0.867, P = 0.001; r(s BMI, HER2+) = 0.636, P = 0.048), but the ER+ rates did not vary by increasing BMI. Controlling for confounding factors, multivariate logistic regression models with BMI<24 kg/m(2) as the reference group were performed and found that BMI≥24 kg/m(2) was only positively correlated with PR+ status among post-menopausal breast cancer cases (adjusted OR = 1.420, 95% CI: 1.116–1.808, Wald = 8.116, P = 0.004). CONCLUSIONS: Post-menopausal women with high BMI (≥24 kg/m(2)) have a higher proportion of PR+ breast cancer. In addition to effects mediated via the estrogen metabolism pathway, high BMI might increase the risk of breast cancer by other routes, which should be examined further in future etiological mechanism studies. |
format | Online Article Text |
id | pubmed-3906138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39061382014-01-31 Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China Li, Jing Huang, Yuan Zhang, Bao-Ning Fan, Jin-Hu Huang, Rong Zhang, Pin Wang, Shu-Lian Zheng, Shan Zhang, Bin Yang, Hong-Jian Xie, Xiao-Ming Tang, Zhong-Hua Li, Hui He, Jian-Jun Hsieh, Evelyn Qiao, You-Lin Li, Jia-Yuan PLoS One Research Article BACKGROUND: Few studies have investigated the association between body mass index (BMI) and breast cancer with consideration to estrogen/progesterone/human epidermal growth factor type 2 receptor status (ER/PR/HER2) in the breast tissue among Chinese pre- and post-menopausal women. METHODS: Four thousand two hundred and eleven breast cancer patients were selected randomly from seven geographic regions of China from 1999 to 2008. Demographic data, risk factors, pathologic features, and biological receptor status of cases were collected from the medical charts. Chi-square test, fisher exact test, rank-correlation analysis, and multivariate logistic regression model were adopted to explore whether BMI differed according to biological receptor status in pre- and post-menopausal women. RESULTS: Three thousand two hundred and eighty one eligible cases with BMI data were included. No statistically significant differences in demographic characteristics were found between the cases with BMI data and those without. In the rank-correlation analysis, the rates of PR+ and HER2+ were positively correlated with increasing BMI among post-menopausal women (r(s BMI, PR+) = 0.867, P = 0.001; r(s BMI, HER2+) = 0.636, P = 0.048), but the ER+ rates did not vary by increasing BMI. Controlling for confounding factors, multivariate logistic regression models with BMI<24 kg/m(2) as the reference group were performed and found that BMI≥24 kg/m(2) was only positively correlated with PR+ status among post-menopausal breast cancer cases (adjusted OR = 1.420, 95% CI: 1.116–1.808, Wald = 8.116, P = 0.004). CONCLUSIONS: Post-menopausal women with high BMI (≥24 kg/m(2)) have a higher proportion of PR+ breast cancer. In addition to effects mediated via the estrogen metabolism pathway, high BMI might increase the risk of breast cancer by other routes, which should be examined further in future etiological mechanism studies. Public Library of Science 2014-01-29 /pmc/articles/PMC3906138/ /pubmed/24489874 http://dx.doi.org/10.1371/journal.pone.0087224 Text en © 2014 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Li, Jing Huang, Yuan Zhang, Bao-Ning Fan, Jin-Hu Huang, Rong Zhang, Pin Wang, Shu-Lian Zheng, Shan Zhang, Bin Yang, Hong-Jian Xie, Xiao-Ming Tang, Zhong-Hua Li, Hui He, Jian-Jun Hsieh, Evelyn Qiao, You-Lin Li, Jia-Yuan Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China |
title | Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China |
title_full | Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China |
title_fullStr | Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China |
title_full_unstemmed | Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China |
title_short | Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China |
title_sort | body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in china |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906138/ https://www.ncbi.nlm.nih.gov/pubmed/24489874 http://dx.doi.org/10.1371/journal.pone.0087224 |
work_keys_str_mv | AT lijing bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT huangyuan bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT zhangbaoning bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT fanjinhu bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT huangrong bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT zhangpin bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT wangshulian bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT zhengshan bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT zhangbin bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT yanghongjian bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT xiexiaoming bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT tangzhonghua bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT lihui bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT hejianjun bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT hsiehevelyn bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT qiaoyoulin bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina AT lijiayuan bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina |